Cyclodextrin for treating lymphedema
A recent patent application of NATIONAL UNIVERSITY OF SINGAPORE claims for the treatment of lymphedema by using empty cyclodextrin (beta-cyclodextrin
A forum for researchers, students and applicants in the field of cyclodextrin technology
A recent patent application of NATIONAL UNIVERSITY OF SINGAPORE claims for the treatment of lymphedema by using empty cyclodextrin (beta-cyclodextrin
The patent application (1) with priority date of 09. March 2020 claims that methyl bCD preferably with DS 0.7 (Crysmeb)
Yahoo Finance published: Working with Professor Steve Wicks and his team at the University of Greenwich, Curadev developed a new method for
China National Intellectual Property Administration (CNIPA) announced the top 10 patent reexamination & invalidation cases in 2020 at its Open
SENS Research Foundation (USA, California) filed a PCT patent application (WO2020142716) that was recently published. In the invention, a new class
There is a not extremely recent but certainly very interesting patent application related to a special use of cyclodextrins, namely
Researchers from Kumamoto University (Hidetoshi Arima, Keiichi Motoyama, Taishi Higashi) filed an international patent application on a novel synthesis of
Although there are several commercial examples for the uses of cyclodextrins as taste-masking agents (Nicorette, Ulgut, Zyrtec, etc), their use
Development of generic formulations with cyclodextrins for oral delivery has been neglected for several decades, since the CD-enabled formulations often
Several cyclodextrins have been claimed by dozens of papers including huge works of Serno [1] and Hartl [2] to be